Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 37 | eprotein:L37F; | CL-1b;CL-3b;CL-5; |
| 37 | eprotein:L37H; | CL-3e; |
| 37 | eprotein:L37T; | CL-3e; |
| 39 | eprotein:L39-; | CL-2;CL-3e; |
| 51 | eprotein:L51-; | CL-3b;CL-3e; |
| 51 | eprotein:L51F; | CL-3b;CL-3d; |
| 73 | eprotein:L73P; | CL-3e; |
| 73 | eprotein:L73V; | CL-3b; |
| 74 | eprotein:L74M; | CL-3d;CL-3e; |
| 74 | eprotein:L74P; | CL-2; |
| 74 | eprotein:L74V; | CL-3e; |
| 15 | eprotein:N15D; | CL-3e; |
| 45 | eprotein:N45D; | CL-3b; |
| 48 | eprotein:N48S; | CL-3e; |
| 64 | eprotein:N64S; | CL-3e;CL-3f; |
| 64 | eprotein:N64T; | CL-3e; |
| 66 | eprotein:N66H; | CL-1b;CL-3e; |
| 66 | eprotein:N66T; | CL-3d;CL-3e; |
| 54 | eprotein:P54-; | CL-3b;CL-3d;CL-3e; |
| 54 | eprotein:P54S; | CL-2; |
| 38 | eprotein:R38-; | CL-2;CL-3e; |
| 38 | eprotein:R38G; | CL-3e; |
| 61 | eprotein:R61-; | CL-3f; |
| 61 | eprotein:R61C; | CL-5; |
| 61 | eprotein:R61L; | CL-3c; |
| 69 | eprotein:R69-; | CL-3b;CL-3e; |
| 69 | eprotein:R69G; | CL-3c; |
| 69 | eprotein:R69T; | CL-3c; |
| 16 | eprotein:S16N; | CL-3d;CL-3e;CL-3f; |
| 50 | eprotein:S50G; | CL-1b;CL-3d; |
| 50 | eprotein:S50I; | CL-3e;CL-3f; |
| 55 | eprotein:S55-; | CL-1b;CL-3b;CL-3e; |
| 6 | eprotein:S6-; | CL-2;CL-3e; |
| 60 | eprotein:S60-; | CL-3b; |
| 60 | eprotein:S60Y; | CL-3e; |
| 67 | eprotein:S67F; | CL-3f; |
| 67 | eprotein:S67P; | CL-3d;CL-3e; |
| 68 | eprotein:S68T; | CL-3c; |
| 68 | eprotein:S68Y; | CL-1b;CL-3c; |
| 6 | eprotein:S6A; | CL-3e; |
| 6 | eprotein:S6L; | CL-3d;CL-5; |
| 30 | eprotein:T30-; | CL-3e; |
| 30 | eprotein:T30A; | CL-3d;CL-3e; |
| 30 | eprotein:T30I; | CL-2;CL-2_4;CL-3a;CL-3b;CL-3c;CL-3d;CL-3e;CL-5; |
| 35 | eprotein:T35F; | CL-3e; |
| 35 | eprotein:T35P; | CL-3e; |
| 9 | eprotein:T9-; | CL-3b;CL-3e;CL-3f; |
| 9 | eprotein:T9A; | CL-3b; |
| 14 | eprotein:V14-; | CL-3e; |
| 17 | eprotein:V17A; | CL-3e; |
Page 130 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com